Clinical Trial Update: The FARAPULSE PersAFOne III Trial for the Treatment of Persistent Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial update for the FARAPULSE PersAFOne III study evaluating pulsed-field ablation for persistent atrial fibrillation; the Phase III trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2025-01-08